Zahaa Aldeen Jamal
Research Subjects
Research Interests
Zahaa Aldeen Jamal has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Abdalfattah Sharad
Madenat Alelem University College
1 shared publication - Hasanain Amer Naji1 shared publication
- Hastyar Hamarashid Najmuldeen
Department of Medical Laboratory Analysis, College of Health Sciences, Cihan University Sulaimaniya, Sulaymaniyah City, Kurdistan, Iraq
1 shared publication - Imad Ghanem Qasim1 shared publication
- Israilova Zeinep Abdukalykovna1 shared publication
- Murzaeva Mariia1 shared publication
Latest Publications
- Open Access
- 14 November 2025
- Published by UK Scientific Publishing Limited in Trends in Immunotherapy
- p. 120-129
Immune Response to Probiotics and Physical Activity: A Clinical Study
This study assessed the effect of probiotic supplementation on immune response in physically active males before and after exhausting exercise. With growing evidence linking gut health to immune function, the aim was to determine whether 12 weeks of probiotics could influence key immune markers in athletes. In this semi-experimental study, 28 male athletes (18–35 years) from sports centers in Osh City, Kyrgyzstan, who engaged in regular training (≥ 3 days/week for ≥ 3 years) were randomly assigned to probiotic or placebo groups. Baseline characteristics included age (20.98 ± 5.9 years), weight (62.3 ± 9.8 kg), height (168.2 ± 7.6 cm), BMI (22.05 ± 2.4 kg/m²), and VO₂ max (59.98 ± 8.8 ml/kg/min), with no significant differences between groups. Immune markers—cell blood count (CBC), C-reactive protein (CRP), and immunoglobulin A (IgA)—were monitored at rest and after exercise. Probiotic supplementation resulted in a significant increase in monocyte levels at rest and during activity compared to placebo. Within the probiotic group, lymphocyte, monocyte, and granulocyte percentages rose significantly during activity (p < 0.001). These results indicate that probiotics may positively modulate immune function in athletes under high physical stress. Given that intense training can suppress immunity and increase susceptibility to illness, probiotic use may enhance gut microbiota, supporting immune resilience. A balanced microbiome not only aids digestion and nutrient absorption but also plays a vital role in regulating inflammation and immune responses. These findings support probiotics as a potential strategy to maintain immune health in physically active populations, warranting further investigation into strain-specific effects and long-term benefits.
- 14 November 2025
- Published by UK Scientific Publishing Limited in Trends in Immunotherapy
- p. 120-129
Open AccessImmune Response to Probiotics and Physical Activity: A Clinical Study
This study assessed the effect of probiotic supplementation on immune response in physically active males before and after exhausting exercise. With growing evidence linking gut health to immune function, the aim was to determine whether 12 weeks of probiotics could influence key immune markers in athletes. In this semi-experimental study, 28 male athletes (18–35 years) from sports centers in Osh City, Kyrgyzstan, who engaged in regular training (≥ 3 days/week for ≥ 3 years) were randomly assigned to probiotic or placebo groups. Baseline characteristics included age (20.98 ± 5.9 years), weight (62.3 ± 9.8 kg), height (168.2 ± 7.6 cm), BMI (22.05 ± 2.4 kg/m²), and VO₂ max (59.98 ± 8.8 ml/kg/min), with no significant differences between groups. Immune markers—cell blood count (CBC), C-reactive protein (CRP), and immunoglobulin A (IgA)—were monitored at rest and after exercise. Probiotic supplementation resulted in a significant increase in monocyte levels at rest and during activity compared to placebo. Within the probiotic group, lymphocyte, monocyte, and granulocyte percentages rose significantly during activity (p < 0.001). These results indicate that probiotics may positively modulate immune function in athletes under high physical stress. Given that intense training can suppress immunity and increase susceptibility to illness, probiotic use may enhance gut microbiota, supporting immune resilience. A balanced microbiome not only aids digestion and nutrient absorption but also plays a vital role in regulating inflammation and immune responses. These findings support probiotics as a potential strategy to maintain immune health in physically active populations, warranting further investigation into strain-specific effects and long-term benefits.
- Open Access
- 30 October 2025
- Published by UK Scientific Publishing Limited in Trends in Immunotherapy
- p. 73-85
Glycoprotein G-Based Vaccines for Nipah Virus: Epidemiology, Molecular Insights, Benefits, and Limitations
Nipah virus (NiV) is a highly virulent zoonotic pathogen associated with significant mortality rates and limited treatment options, posing a significant public health threat. This review explores the epidemiology, molecular structure, and vaccine development efforts targeting glycoprotein G, a critical component of the virus's entry mechanism. Advances in structural biology and immunogenetics have highlighted the potential of glycoprotein G-based vaccines in preventing NiV infections. Despite promising preclinical results, challenges such as immune evasion, safety concerns, and limited clinical trials persist. Additionally, we examine the benefits of glycoprotein G-based vaccines in enhancing immune responses and preventing viral entry, as well as the limitations posed by genetic diversity and cross-reactivity. This review highlights the critical need for ongoing research to overcome existing challenges and guide future vaccine development efforts against NiV. It further underscores the necessity of innovative approaches in vaccine design to reduce the global burden of NiV infections. Glycoprotein G-based vaccines represent a promising avenue for combating NiV infections. Advances in structural biology, immune system targeting, and delivery system technology are paving the way for more effective vaccines. However, overcoming challenges such as cross-reactivity and safety concerns will require continued innovation and collaboration.
- 30 October 2025
- Published by UK Scientific Publishing Limited in Trends in Immunotherapy
- p. 73-85
Open AccessGlycoprotein G-Based Vaccines for Nipah Virus: Epidemiology, Molecular Insights, Benefits, and Limitations
Nipah virus (NiV) is a highly virulent zoonotic pathogen associated with significant mortality rates and limited treatment options, posing a significant public health threat. This review explores the epidemiology, molecular structure, and vaccine development efforts targeting glycoprotein G, a critical component of the virus's entry mechanism. Advances in structural biology and immunogenetics have highlighted the potential of glycoprotein G-based vaccines in preventing NiV infections. Despite promising preclinical results, challenges such as immune evasion, safety concerns, and limited clinical trials persist. Additionally, we examine the benefits of glycoprotein G-based vaccines in enhancing immune responses and preventing viral entry, as well as the limitations posed by genetic diversity and cross-reactivity. This review highlights the critical need for ongoing research to overcome existing challenges and guide future vaccine development efforts against NiV. It further underscores the necessity of innovative approaches in vaccine design to reduce the global burden of NiV infections. Glycoprotein G-based vaccines represent a promising avenue for combating NiV infections. Advances in structural biology, immune system targeting, and delivery system technology are paving the way for more effective vaccines. However, overcoming challenges such as cross-reactivity and safety concerns will require continued innovation and collaboration.